Toggle light / dark theme

Two astronauts from the International Space Station (ISS) yesterday performed the first spacewalk of the year, working on the exterior of the station as part of a long-term program to upgrade the ISS power system. The spacewalk took place on Friday, January 20, and lasted over seven hours, though one troublesome strut wasn’t bolted into place as planned.

The two astronauts performing the spacewalk were NASA astronaut Nicole Mann and Japan Aerospace Exploration Agency (JAXA) astronaut Koichi Wakata, and this was the first spacewalk for each of them.

The ISS solar arrays which provide power to the station are getting old, so in a long-term project astronauts are installing new arrays called iROSAs at an offset on top of the old arrays — allowing both sets of arrays to provide power. The aim of the spacewalk yesterday was to install two mounting platforms, which would be used to install new solar arrays later this year.

University of Queensland researchers have identified a pathway in cells that could be used to reprogram the body’s immune system to fight back against both chronic inflammatory and infectious diseases.

Dr. Kaustav Das Gupta and Professor Matt Sweet from UQ’s Institute for Molecular Bioscience discovered that a molecule derived from glucose in can both stop bacteria growing and dampen . Dr. Das Gupta said that the finding is a critical step towards future therapeutics that train immune cells.

The research was published in Proceedings of the National Academy of Sciences (PNAS).

See the people building up Atlas.


How does Atlas recognize and interact with objects? How do we develop new Atlas behaviors? Why is manipulation important for the future of robotics?

Join our team in the Atlas lab to discover the answers to these questions and more. Keep reading on our blog: https://www.bostondynamics.com/resources/blog/sick-tricks-and-tricky-grips.

A new study has identified a promising drug candidate that can protect neurons from degeneration in mouse models of Parkinson’s disease. The research is published in Science Translational Medicine.

Addressing an unmet need

Parkinson’s disease (PD) is the second most common neurodegenerative disease, and over the last 25 years, the prevalence of PD has doubled, presenting a large health burden across the globe.

The artificial intelligence (AI) chatbot ChatGPT that has taken the world by storm has made its formal debut in the scientific literature, pulling up at least four authorship credits on published papers and preprints.

Editors, researchers, and publishers are currently debating whether such AI tools should be included in published literature and whether the bot should be cited as an author. Publishers are thinking of policies to be created for chatbots like chatgpt.

Research publications and preprint servers stated that AIs like ChatGPT don’t meet the criteria for study authors. They cannot assume responsibility for scientific papers. Some publishers claim that an AI’s contributions to writing papers can be recognized in sections other than those on the author list.

Luwu Dynamics products are quadruped robot dogs with 12 degrees of freedom. They are used for teenagers to learn Artificial Intelligence Programming. They can realize omni-directional movement, six-dimensional attitude control, attitude stability and a variety of motion gait. They are internally equipped with 9-axis IMU, joint position sensor and current sensor to feed back their own attitude, joint angle and torque for internal algorithm and secondary development, It can off-line AI functions such as face recognition, image classification, gesture recognition, speech recognition, audio analysis and target tracking, and supports cross platform graphical and python programming.

luwu

An interesting interview conducted at a conference workshop with 3 experts discussing what is AI and how it is impacting the world of scientific publishing.


A recap of a recent SSP webinar on artificial intelligence (AI) and scholarly publishing. How can this set of technologies help or harm scholarly publishing, and what are some current trends? What are the risks of AI, and what should we look out for?